Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
Frequently asked questions
What sector does Celltrion Pharm Inc (068760) operate in?
Celltrion Pharm Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Celltrion Pharm Inc (068760) current stock price?
As of the latest data, Celltrion Pharm Inc stock price is ₩44,650, with a previous close of ₩44,450. Celltrion Pharm Inc gained ₩200 in the last trading session, representing a 0.45% increase.
What is Celltrion Pharm Inc (068760) current market capitalization?
Celltrion Pharm Inc market cap is approximately 1.98 trillion.
Does Celltrion Pharm Inc (068760) pay dividends?
Yes. Celltrion Pharm Inc pays annual dividends with an annualized yield of 0.45% and an estimated annual payout of ₩200 per share.
When is the next ex-dividend date for Celltrion Pharm Inc (068760)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Celltrion Pharm Inc (068760) beta (volatility) score?
Celltrion Pharm Inc has a beta of 0.942, meaning its volatility is roughly in line with the market.
